Open AccessSpinal Cord Stimulator for Treating Chemotherapy-induced Peripheral Neuropathy
Publication year - 2021
Publication title -
interventional pain management reports
Language(s) - English
Resource type - Journals
ISSN - 2575-9841
DOI - 10.36076/pmcr.2021.5.223
Subject(s) - medicine , peripheral neuropathy , chemotherapy induced peripheral neuropathy , spinal cord , chemotherapy , spinal cord stimulator , peripheral , adverse effect , conservative management , spinal cord stimulation , anesthesia , quality of life (healthcare) , stimulation , surgery , nursing , endocrinology , psychiatry , diabetes mellitus
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is not only one of the most common adverse experiences of cancer survivors, but it is also one which has the greatest effect on quality of life. Ultimately, CIPN can lead to unwanted modification of treatment such as chemotherapy dose reductions or termination of treatment altogether.CASE REPORT: We present a case of a 47-year-old man with severe bilateral CIPN resistant to conservative management, who was successfully treated with spinal cord stimulation.CONCLUSION: Spinal cord stimulation can be an effective treatment for CIPN resistant to conservative management.KEY WORDS: Spinal cord stimulator, chemotherapy induced neuropathy, peripheral neuropathy